These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38333112)

  • 1. Plasma ddPCR for the detection of
    Su JW; Weng CD; Lin XC; Fang MM; Xiao X; Zhang YC; Zhang XC; Su J; Xu CR; Yan HH; Chen HJ; Wu YL; Yang JJ
    Ther Adv Med Oncol; 2024; 16():17588359241229435. PubMed ID: 38333112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer.
    Fan Y; Sun R; Wang Z; Zhang Y; Xiao X; Liu Y; Xin B; Xiong H; Lu D; Ma J
    J Cancer Res Clin Oncol; 2023 May; 149(5):1667-1677. PubMed ID: 35583827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients.
    Zhang H; Hu Y; Wang Y; Song X; Hu Y; Ma L; Yang X; Li K; Qin N; Wang J; Lv J; Li X; Zhang X; Zhang Q; Wu Y; Yao G; Zhang S
    Front Oncol; 2022; 12():942123. PubMed ID: 36776375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of different methods for detecting T790M mutation in the plasma of patients with advanced NSCLC after developing resistance to first-generation EGFR-TKIs in a real-world clinical setting.
    Hou T; Zeng J; Xu H; Su S; Ye J; Li Y
    Mol Clin Oncol; 2022 Apr; 16(4):88. PubMed ID: 35251639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Nine Oncogenes Amplification in Lung and Colorectal Cancer Formalin-Fixed Paraffin-Embedded Tissue Samples using Combined Next-Generation Sequencing-Based Script and Digital Droplet Polymerase Chain Reaction.
    Bontoux C; Guyard A; Lupo A; Diallo K; Rebah K; Hercent A; Guenzi E; Cros J; Lamoril J; Leroy K; Theou-Anton N
    Cancer Control; 2023; 30():10732748231167257. PubMed ID: 37386758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in advanced NSCLC with different T790M statuses tested via digital droplet polymerase chain reaction ddPCR and next-generation sequencing.
    Xu Z; Li Y; Wang L; Hao X; Ying J; Li J; Xing P
    Expert Rev Anticancer Ther; 2024; 24(3-4):183-192. PubMed ID: 38526910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate Measure.
    Saw SPL; Tan GS; Tan WC; Tan AC; Lai GGY; Lim DWT; Kanesvaran R; Tan WL; Tan SH; Lim KH; Skanderup AJ; Tan DSW
    JTO Clin Res Rep; 2023 Dec; 4(12):100599. PubMed ID: 38162173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Value of Droplet Digital PCR and Super-ARMS Detection of Epidermal Growth Factor Receptor Gene Mutation in Plasma Circulating Tumor DNA of Patients with Advanced Lung Adenocarcinoma].
    Cao Z; Wang J; Qin N; Li K; Lv J; Wang J; Yang X; Li X; Zhang H; Zhang Q; Long H; Shu C; Ma L; Zhang S
    Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):84-90. PubMed ID: 32093452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of ARMS-Plus and droplet digital PCR for detecting EGFR activating mutations in plasma.
    Zhang X; Chang N; Yang G; Zhang Y; Ye M; Cao J; Xiong J; Han Z; Wu S; Shang L; Zhang J
    Oncotarget; 2017 Dec; 8(67):112014-112023. PubMed ID: 29340107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimertinib.
    Ding PN; Becker T; Bray V; Chua W; Ma Y; Xu B; Lynch D; de Souza P; Roberts T
    Thorac Cancer; 2019 Oct; 10(10):1879-1884. PubMed ID: 31414729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
    Li Y; Zhang FS; Guo L; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay.
    Guo QM; Wang L; Yu WJ; Qiao LH; Zhao MN; Hu XM; Sun YM; Ni S; Xu YH; Lou JT
    J Cancer; 2019; 10(18):4341-4349. PubMed ID: 31413754
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastases.
    Chiang CL; Ho HL; Yeh YC; Lee CC; Huang HC; Shen CI; Luo YH; Chen YM; Chiu CH; Chou TY
    Thorac Cancer; 2023 May; 14(14):1251-1259. PubMed ID: 36977550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors.
    Peng LX; Jie GL; Li AN; Liu SY; Sun H; Zheng MM; Zhou JY; Zhang JT; Zhang XC; Zhou Q; Zhong WZ; Yang JJ; Tu HY; Su J; Yan HH; Wu YL
    Exp Hematol Oncol; 2021 Nov; 10(1):52. PubMed ID: 34758872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the SuperARMS and Droplet Digital PCR for Detecting EGFR Mutation in ctDNA From NSCLC Patients.
    Feng WN; Gu WQ; Zhao N; Pan YM; Luo W; Zhang H; Liang JM; Yang J; Deng YM
    Transl Oncol; 2018 Apr; 11(2):542-545. PubMed ID: 29525631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical value of droplet digital polymerase chain reaction method in detecting plasma circulating tumor deoxyribonucleic acid epidermal growth factor receptor mutations in advanced pulmonary adenocarcinoma patients].
    Ma L; Lü JL; Li K; Wang JH; Yang XJ; Li X; Zhang H; Zhang Q; Qin N; Zhang SC
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(29):2336-2340. PubMed ID: 30107692
    [No Abstract]   [Full Text] [Related]  

  • 17. Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer.
    Guibert N; Hu Y; Feeney N; Kuang Y; Plagnol V; Jones G; Howarth K; Beeler JF; Paweletz CP; Oxnard GR
    Ann Oncol; 2018 Apr; 29(4):1049-1055. PubMed ID: 29325035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of
    Sun B; Qiu T; Zeng X; Duan J; Bai H; Xu J; Li J; Li J; Hao X; Liu Y; Lin L; Wang H; Zhang X; Zhong J; Wang J; Ying J; Wang Z
    Cancer Res Commun; 2023 Apr; 3(4):532-539. PubMed ID: 37025355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of EGFR T790M detection by ddPCR and ARMS-PCR and the effect of mutant abundance on the efficacy of osimertinib in NSCLC patients.
    Li Y; Xu Y; Wu X; He C; Liu Q; Wang F
    J Thorac Dis; 2019 Jul; 11(7):3004-3014. PubMed ID: 31463130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.